PTC Therapeutics presents new Sephience data
PTC Therapeutics says new Sephience (sepiapterin) data reinforce sustained metabolic control, diet liberalization and a consistent favorable safety profile.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.